Malvinder S Parmar. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Combined Modality TherapyFemaleHumansHyperprolactinemia/diagnosisHyperprolactinemia/etiologyHyperprolactinemia/therapyPituitary Neoplasms/complicationsPituitary Neoplasms/diagnosisPituitary Neoplasms/therapyPrognosisProlactin/analysisProlactin/metabolismRisk Assessment
Substances: See more » Prolactin
Year: 2004 PMID: 14734418 PMCID: PMC315509
Source DB: PubMed Journal: CMAJ ISSN: 0820-3946 Impact factor: 8.262